GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Other Income (Minority Interest)

CanadaBis Capital (TSXV:CANB) Other Income (Minority Interest) : C$0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. CanadaBis Capital's Other Income (Minority Interest) for the three months ended in Jan. 2024 was C$0.00 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.


CanadaBis Capital Other Income (Minority Interest) Historical Data

The historical data trend for CanadaBis Capital's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Other Income (Minority Interest) Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
Other Income (Minority Interest)
Get a 7-Day Free Trial - - - - -

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Income (Minority Interest) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CanadaBis Capital Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus

Can B Corp.'s Pure Health Products Awarded NSF's GMP Certification

By GuruFocusNews GuruFocusNews 12-30-2021